Irlanda - inglés - HPRA (Health Products Regulatory Authority)

elanco gmbh - tylosin (as tylosin tartrate) - powder for oral solution - 100 gram(s) - tylosin

Reino Unido - inglés - VMD (Veterinary Medicines Directorate)

elanco europe ltd - tylosin - solution for injection - antimicrobial - cattle, pigs

Australia - inglés - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - restylane lidocaine is a sterile, transparent, biodegradable gel of stabilized hyaluronic acid with the addition of 0.3% lidocaine hydrochloride and is supplied in a glass syringe and disposable 29g thin wall needles are provided with the device. the device is a filler that adds volume to the tissue, thereby restoring the skin contours or enhancing the lips to the desired level of correction. the volume and lifting capacity originate from the ability of stabilized hyaluronic acid to bind water. restylane lidocaine is intended to be used for facial tissue augmentation. it is recommended to be used for the correction of wrinkles and for lip enhancement. it should be injected into the middle part of the dermis layer or in the submucosal layer of the lip. for facial areas with limited soft tissue support and soft tissue cover, e.g. the periorbital region, injection into the subcutaneous fatty tissue or supraperiostal administration are recommended. the addition of lidocaine provides a pain relieving effect during

Australia - inglés - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - restylane lyps lidocaine is a sterile, transparent, biodegradable gel consisting of stabilized hyaluronic acid of non-animal origin in phosphate buffered saline at a concentration 20mg/ml, with the addition of 3mg/ml lidocaine hydrochloride. it is supplied in a glass syringe with a volume of 1 ml. the contents of the syringe are sterilized using moist heat. the product is for single use only. disposable 29gtw (thin-walled) needles sterilized using ethylene oxide are provided. restylane lyps lidocaine is intended for lip enhancement. it should be administered by submucosal injection. the addition of lidocaine provides a pain relieving effect during treatment.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - restylane lyft lidocaine is a sterile, transparent, biodegradable gel of stabilized hyaluronic acid with addition of 0.3% lidocaine hydrochloride and is supplied in a glass syringe. disposable 27g thin wall needles are provided with the device. the device is a filler that adds volume to the tissue, thereby restoring the skin contours or enhancing the lips to the desired level of correction. . the volume and lifting capacity originate from the ability of stabilized hyaluronic acid to bind water. restylane lyft lidocaine is intended to be used for facial tissue augmentation. it is recommended to be used for shaping the contours of the face, the correction of folds and for lip enhancement. it should be injected into deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds, or in the submucosal layer of the lip. for cheek augmentation, correction of age-related midface contour deficiencies and facial areas with limited soft tissue support and

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - tylosin tartrate; trenbolone acetate; oestradiol - parenteral implant, device - tylosin tartrate antibiotic active 29.0 mg/im; trenbolone acetate steroid-anabolic active 60.0 mg/im; oestradiol steroid-estrogen active 12.0 mg/im - nutrition & metabolism - heifer - pasture fed | steer- pasture fed - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Australia - inglés - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - restylane kysse is a sterile, biodegradable, transparent gel of non-animal cross-linked hyaluronic acid at a concentration of 20mg/ml in phosphate buffered saline with the addition of lidocaine hydrochloride 3 mg/ml. gel is supplied in a prefilled syringe volume of 1 ml. contents of the syringe are sterilized using moist heat. syringe is packaged individually in a blister, with two 30g x ?" ultra thin wall needles. the needles have been sterilized using ethylene oxide. product is single use only restylane kysse is intended to restore or augment the volume of the lips. it should be injected into the submucosal layer of the lip. lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - restylane volyme is a sterile, biodegradable, transparent gel of non-animal cross-linked hyaluronic acid in phosphate buffered saline at a concentration 20mg/ml with the addition of lidocaine hydrochloride 3 mg/ml. the gel is supplied in a pre-filled syringe (1ml) and is sterilized using moist heat. the syringe is packaged individually in a blister, with two 27g x1/2? ultra thin wall needles. the needles have been sterilized using irradiation. the product is for single use only. restylane volyme is intended to augment the volume of facial tissues. it is recommended to be used for the correction of facial volume, for instance cheeks and chin. depending on the area to be treated and the tissue support, the product should be injected into the supraperiostic zone or subcutis. lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - restylane refyne is a sterile, biodegradable, transparent gel of non-animal cross-linked hyaluronic acid in phosphate buffered saline at a concentration of 20mg/ml with the addition of lidocaine hydrochloride 3 mg/ml. the gel is supplied in a prefilled syringe (1ml) and is sterilized using moist heat.. the syringe is packaged individually in a blister, with two 30g x1/2? ultra thin wall needles. the needles have been sterilized using irradiation. the product is for single use only. restylane refyne is intended to augment the volume of facial tissues. it is recommended to be used for correction of moderate wrinkles, or to redefine the shape of the lips, cheeks or tear troughs. depending on the area to be treated and the tissue support, the product should be injected in the mid to deep dermis, submucosal layer of the lips, subcutis or supraperiostic zone. lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - restylane defyne is a sterile, biodegradable, transparent gel of non-animal cross-linked hyaluronic acid in phosphate buffered saline at a concentration of 20 mg/ml with the addition of lidocaine hydrochloride 3 mg/ml. the gel is supplied in a prefilled syringe (1ml) and sterilized using moist heat. the syringe is packaged individually in a blister, with two 27g x ?? ultra thin wall needles. the needles have been sterilized using irradiation. the product is for single use only. restylane defyne is intended to augment the volume of facial tissues. it is recommended to be used for correction of severe wrinkles, or to redefine the shape of the lips, cheeks or tear troughs. depending on the area to be treated and the tissue support, the product should be injected in the mid to deep dermis, submucosal layer of the lips, subcutis or supraperiostic zone. lidocaine is added to the formulation to diminish the pain resulting from the injection during the treatment.